Literature DB >> 25301917

Venous thromboembolism in malignancy.

Anna Mullard1, Helen Innes2.   

Abstract

Entities:  

Keywords:  Venous thromboembolism; incidental; low-molecular-weight heparin; malignancy; primary prophylaxis

Mesh：

Year:  2014        PMID： 25301917      PMCID： PMC4951965          DOI： 10.7861/clinmedicine.14-5-532

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN： 1470-2118            Impact factor:   2.659


× No keyword cloud information.
  4 in total

1.  Adrenocorticotropic hormone-secreting pancreatic neuroendocrine carcinoma with multiple organ infections and widespread thrombosis: A case report.

Authors:  Akihiro Yoshihara; Kota Nishihama; Chisa Inoue; Yuko Okano; Kazuhito Eguchi; Soichiro Tanaka; Kanako Maki; Valeria Fridman D'Alessandro; Atsuro Takeshita; Taro Yasuma; Mei Uemura; Toshinari Suzuki; Esteban C Gabazza; Yutaka Yano
Journal:  World J Clin Cases       Date:  2022-06-16       Impact factor: 1.534

2.  CCN3 is a therapeutic target relating enhanced stemness and coagulation in hepatocellular carcinoma.

Authors:  Qingan Jia; Tongchun Xue; Qiangbo Zhang; Wei Cheng; Chun Zhang; Jingwei Ma; Yang Bu; Songning Yu; Qingguang Liu
Journal:  Sci Rep       Date:  2017-10-23       Impact factor: 4.379

3.  Venous Thromboembolism in Hospitalized Melanoma Patients: Analysis from the National Inpatient Sample Database.

Authors:  Hussam Alhasson; Kadhim Al-Banaa; Mohammad Abu-Tineh; Bassam Alhasson; Yu Zhao; Mohamed A Yassin
Journal:  Int J Gen Med       Date:  2021-11-09

4.  Venous thromboembolism in patients with adrenocortical carcinoma after surgery.

Authors:  Jülide Durmuşoğlu; Henri J L M Timmers; Pepijn van Houten; Johan F Langenhuijsen; Ad R M M Hermus; Annenienke C van de Ven
Journal:  Endocr Connect       Date:  2020-10       Impact factor: 3.335
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.